Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SODIUM AUROTIOSULFATE: 99 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
99
Total FAERS Reports
89 (89.9%)
Deaths Reported
72
Hospitalizations
99
As Primary/Secondary Suspect
65
Life-Threatening
72
Disabilities

First Report: 20080101 · Latest Report: 20150818

What Are the Most Common SODIUM AUROTIOSULFATE Side Effects?

#1 Most Reported
Drug intolerance
76 reports (76.8%)
#2 Most Reported
Drug ineffective
71 reports (71.7%)
#3 Most Reported
Synovitis
70 reports (70.7%)

All SODIUM AUROTIOSULFATE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug intolerance 76 76.8% 71 52
Drug ineffective 71 71.7% 63 46
Synovitis 70 70.7% 63 46
Hypertension 68 68.7% 61 46
Product use issue 68 68.7% 61 44
Intentional product use issue 67 67.7% 66 43
Treatment failure 67 67.7% 60 43
Contraindicated product administered 65 65.7% 58 42
Product use in unapproved indication 65 65.7% 65 41
Vomiting 65 65.7% 65 41
Abdominal discomfort 64 64.7% 57 42
Alopecia 64 64.7% 57 42
Arthropathy 64 64.7% 58 42
Therapeutic product effect incomplete 63 63.6% 56 39
Wound 62 62.6% 62 38
Drug hypersensitivity 61 61.6% 54 38
General physical health deterioration 61 61.6% 54 40
Glossodynia 61 61.6% 61 39
Taste disorder 61 61.6% 61 37
Hand deformity 60 60.6% 60 38

Who Reports SODIUM AUROTIOSULFATE Side Effects? Age & Gender Data

Gender: 100.0% female, 0.0% male. Average age: 41.7 years. Most reports from: CA. View detailed demographics →

Is SODIUM AUROTIOSULFATE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2008 1 0 1
2015 4 4 4

View full timeline →

What Is SODIUM AUROTIOSULFATE Used For?

IndicationReports
Product used for unknown indication 85

Official FDA Label for SODIUM AUROTIOSULFATE

Official prescribing information from the FDA-approved drug label.